BUDX logo

Cannabis Growth ETF (BUDX) Análisis de Acciones

Solo con fines informativos. No es asesoramiento financiero. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.

Cotizando a $, Cannabis Growth ETF (BUDX) es una empresa del sector Financial Services valorada en 0. Calificado con 44/100 (cauteloso) en potencial de crecimiento, salud financiera e impulso.

Ultimo analisis: 18 mar 2026
Puntuación de IA de 44/100

Cannabis Growth ETF (BUDX) Perfil de Servicios Financieros

Año de la oferta pública inicial (OPI)2021

Cannabis Growth ETF (BUDX) provides investors exposure to the global legal cannabis industry through a portfolio of exchange-traded equity securities. Operating as a non-diversified fund, BUDX concentrates its investments in cannabis companies, offering a focused approach to this rapidly evolving sector within the broader asset management landscape.

Procedencia de los datos | Datos financieros Análisis cuantitativo NASDAQ Análisis: 18 mar 2026

Tesis de Inversión

Cannabis Growth ETF (BUDX) offers a targeted investment vehicle for those seeking exposure to the expanding global cannabis market. The primary value driver is the growth of the legal cannabis industry worldwide, driven by increasing legalization and acceptance. As more countries and regions legalize cannabis for medical or recreational use, the demand for cannabis products is expected to increase, benefiting companies within the BUDX portfolio. The fund's non-diversified structure allows it to capitalize on the potential high growth of specific cannabis companies. However, investors should be aware of the inherent risks associated with the cannabis industry, including regulatory uncertainties and market volatility. The fund's beta of 1.62 indicates higher volatility compared to the overall market.

Basado en las finanzas de FMP y el análisis cuantitativo

Puntos clave

  • BUDX invests at least 80% of its net assets in exchange-traded equity securities of companies engaged in legal cannabis-related businesses.
  • The fund may invest in other ETFs that also focus on cannabis companies, providing diversified exposure within the sector.
  • BUDX is a non-diversified fund, which allows for concentrated investments in a smaller number of cannabis companies.
  • The fund's investment strategy includes the use of derivatives with economic characteristics similar to cannabis company securities.
  • BUDX's beta of 1.62 suggests a higher level of volatility compared to the broader market, reflecting the speculative nature of the cannabis industry.

Competidores y Pares

Fortalezas

  • Focused exposure to the high-growth cannabis industry.
  • Potential for high returns due to the non-diversified structure.
  • Access to a global portfolio of cannabis companies.
  • Flexibility to invest in other cannabis ETFs and derivatives.

Debilidades

  • High concentration risk due to the non-diversified structure.
  • Vulnerability to regulatory changes and market volatility in the cannabis industry.
  • Limited diversification compared to broader market ETFs.
  • Dependence on the performance of the cannabis sector.

Catalizadores

  • Upcoming: Further legalization of cannabis in key global markets, driving increased demand and investment.
  • Ongoing: Product innovation and development of new cannabis-based products, expanding the market and attracting new consumers.
  • Ongoing: Consolidation within the cannabis industry through mergers and acquisitions, creating larger and more efficient companies.

Riesgos

  • Potential: Regulatory setbacks and changes in cannabis laws, hindering market growth and impacting company valuations.
  • Ongoing: Market volatility and fluctuations in cannabis stock prices, leading to potential losses for investors.
  • Ongoing: Competition from other cannabis ETFs and investment vehicles, impacting market share and returns.
  • Potential: Negative public perception and social stigma associated with cannabis, limiting market acceptance and growth.

Oportunidades de crecimiento

  • Expansion of Legal Cannabis Markets: As more countries and regions legalize cannabis for medical and recreational use, the addressable market for cannabis companies will continue to expand. This growth is expected to drive revenue and earnings growth for companies within the BUDX portfolio. The global legal cannabis market is projected to reach $57 billion by 2027, presenting a significant growth opportunity for BUDX.
  • Increased Acceptance and Adoption: As societal attitudes towards cannabis continue to evolve, increased acceptance and adoption of cannabis products are expected. This trend will likely lead to higher demand for cannabis products and services, benefiting companies in the cannabis industry. Education and awareness campaigns are playing a crucial role in shifting public perception and driving adoption.
  • Product Innovation and Diversification: Cannabis companies are increasingly focused on product innovation and diversification, developing new and innovative cannabis-based products. This includes edibles, beverages, topicals, and other cannabis-infused products. These new products are attracting a wider range of consumers and driving growth in the cannabis market. BUDX can benefit from investing in companies that are at the forefront of product innovation.
  • Mergers and Acquisitions: The cannabis industry is undergoing consolidation, with larger companies acquiring smaller players to gain market share and expand their operations. This trend is creating opportunities for BUDX to invest in companies that are potential acquisition targets or that are actively involved in mergers and acquisitions. Consolidation can lead to increased efficiency and profitability for cannabis companies.
  • Development of Cannabis-Based Pharmaceuticals: The potential for cannabis-based pharmaceuticals is a significant growth driver for the industry. Research and development efforts are underway to develop cannabis-based treatments for various medical conditions. Successful development and commercialization of these pharmaceuticals could generate substantial revenue for cannabis companies and boost the value of BUDX's holdings. Clinical trials and regulatory approvals are key milestones in this area.

Oportunidades

  • Expansion of legal cannabis markets globally.
  • Increased acceptance and adoption of cannabis products.
  • Product innovation and diversification in the cannabis industry.
  • Potential for mergers and acquisitions in the cannabis sector.

Amenazas

  • Regulatory uncertainty and changes in cannabis laws.
  • Competition from other cannabis ETFs and investment vehicles.
  • Market volatility and fluctuations in cannabis stock prices.
  • Negative public perception and social stigma associated with cannabis.

Ventajas competitivas

  • First-mover advantage in offering a dedicated ETF focused on the global cannabis industry.
  • Expertise in selecting and managing investments in cannabis companies.
  • Established relationships with key players in the cannabis industry.
  • Brand recognition and reputation as a leading cannabis ETF.

Acerca de BUDX

Cannabis Growth ETF (BUDX) is designed to provide investors with exposure to the global legal cannabis industry. The fund achieves this by investing primarily in exchange-traded equity securities of companies engaged in legal cannabis-related businesses. These businesses span various aspects of the cannabis industry, including cultivation, processing, distribution, and retail. BUDX operates under the principle of investing at least 80% of its net assets, plus any borrowings for investment purposes, in these cannabis companies. BUDX may also invest in other exchange-traded funds (ETFs) that have a policy to invest at least 80% of their assets in securities of cannabis companies. This allows the fund to gain broader exposure to the sector through diversified investment vehicles. Additionally, BUDX may utilize derivatives that have economic characteristics similar to the securities of cannabis companies, providing further flexibility in its investment strategy. It is important to note that BUDX is a non-diversified fund. This means that it can invest a larger percentage of its assets in a smaller number of issuers compared to a diversified fund. While this strategy can potentially lead to higher returns if the cannabis sector performs well, it also carries a higher level of risk due to the concentration of investments.

Qué hacen

  • Invests in exchange-traded equity securities of companies engaged in legal cannabis-related businesses.
  • Focuses on companies involved in cultivation, processing, distribution, and retail of cannabis.
  • May invest in other ETFs that have a policy to invest in securities of cannabis companies.
  • Utilizes derivatives with economic characteristics similar to cannabis company securities.
  • Provides investors with exposure to the global legal cannabis industry.
  • Operates as a non-diversified fund, concentrating investments in the cannabis sector.

Modelo de Negocio

  • Generates returns through the appreciation of the value of its investments in cannabis companies.
  • Collects management fees from investors based on the fund's assets under management (AUM).
  • May generate income from dividends or interest payments received from its investments.
  • Trades securities within the portfolio to optimize returns and manage risk.

Contexto de la Industria

The asset management industry is evolving with the emergence of specialized ETFs like BUDX, targeting niche sectors such as the cannabis industry. The global cannabis market is experiencing rapid growth, driven by increasing legalization and changing consumer attitudes. This growth presents both opportunities and challenges for asset managers. BUDX operates in a competitive landscape that includes other ETFs and investment vehicles focused on cannabis. The fund's success depends on its ability to effectively select and manage investments in cannabis companies, navigating regulatory complexities and market volatility.

Clientes Clave

  • Individual investors seeking exposure to the cannabis industry.
  • Institutional investors looking to diversify their portfolios with cannabis-related assets.
  • Financial advisors seeking investment options for their clients interested in the cannabis sector.
  • High-net-worth individuals seeking growth opportunities in emerging markets.
Confianza de la IA: 71% Actualizado: 18 mar 2026

Finanzas

Gráfico e información

Precio de la acción de Cannabis Growth ETF (BUDX): Price data unavailable

Últimas noticias

No hay noticias recientes disponibles para BUDX.

Consenso de analistas

Calificación de Consenso

Recomendaciones agregadas de Compra/Mantener/Vender de Benzinga, Yahoo Finance y Finnhub para BUDX.

Objetivos de Precios

Análisis del precio objetivo de Wall Street para BUDX.

MoonshotScore

44/100

¿Qué significa esta puntuación?

El MoonshotScore califica el potencial de crecimiento de BUDX en una escala de 0 a 100 en múltiples factores, incluyendo innovación, disrupción del mercado, salud financiera e impulso.

Lo Que los Inversores Preguntan Sobre Cannabis Growth ETF (BUDX)

¿Cuáles son los factores clave para evaluar BUDX?

Cannabis Growth ETF (BUDX) actualmente tiene una puntuación IA de 44/100, indicando puntuación baja. Fortaleza clave: Focused exposure to the high-growth cannabis industry.. Riesgo principal a monitorear: Potential: Regulatory setbacks and changes in cannabis laws, hindering market growth and impacting company valuations.. Esto no es asesoramiento financiero.

¿Qué es el MoonshotScore de BUDX?

BUDX actualmente puntúa 44/100 (Grado D) en el MoonshotScore, lo que sugiere calificación baja. La puntuación evalúa el potencial de crecimiento, la salud financiera, el impulso del mercado y los factores de riesgo en 9 KPIs cuantitativos. Se recalcula diariamente con los últimos datos del mercado. Esta puntuación es solo informativa.

¿Con qué frecuencia se actualizan los datos de BUDX?

Los precios de BUDX se actualizan en tiempo real durante el horario del mercado estadounidense (9:30-16:00 ET, días laborables). Los fundamentales se actualizan después de los informes trimestrales o anuales. Las calificaciones de analistas y las perspectivas de IA se actualizan diariamente. Las noticias se agregan continuamente de fuentes financieras.

¿Qué dicen los analistas sobre BUDX?

La cobertura de analistas para BUDX incluye calificaciones de consenso (compra, mantener, venta), objetivos de precio a 12 meses y estimaciones de ganancias de las principales firmas de investigación. Consulte la sección de Consenso de Analistas en esta página.

¿Cuáles son los riesgos de invertir en BUDX?

Las categorías de riesgo para BUDX incluyen riesgo de mercado, riesgo específico de la empresa (gestión, competencia), riesgo financiero (deuda, consumo de efectivo) y riesgo macroeconómico (tasas, inflación). Un riesgo clave identificado: Potential: Regulatory setbacks and changes in cannabis laws, hindering market growth and impacting company valuations.. Un beta superior a 1,0 indica mayor volatilidad que el S&P 500. Revise la sección de Factores de Riesgo en esta página. Todas las inversiones conllevan riesgo de pérdida.

¿Cuál es la relación P/E de BUDX?

La relación P/E para BUDX compara el precio actual de la acción con sus ganancias por acción. Un P/E más alto puede indicar expectativas de crecimiento, mientras que un P/E más bajo puede sugerir valor. Consulte la pestaña de Financieros para métricas actuales.

¿Está BUDX sobrevalorada o infravalorada?

Determinar si Cannabis Growth ETF (BUDX) está sobrevalorada o infravalorada requiere examinar múltiples métricas. Compare los ratios de valoración (P/E, P/S, EV/EBITDA) con pares del sector. Esto no es asesoramiento financiero.

¿Cuál es el rendimiento por dividendo de BUDX?

Cannabis Growth ETF (BUDX) actualmente no paga un dividendo regular, o los datos de rendimiento no están disponibles. Consulte la pestaña de Financieros para información actual.

Descargo de responsabilidad: Este contenido es solo para fines informativos y no constituye asesoramiento de inversión. Siempre haga su propia investigación y consulte a un asesor financiero.

Recursos Oficiales

Análisis actualizado el Puntuación de IA actualizada diariamente
Fuentes de Datos y Metodología
Datos de mercado proporcionados por Financial Modeling Prep y Yahoo Finance. Análisis de IA por algoritmos propietarios de Stock Expert AI. Indicadores técnicos mediante cálculos estándar de la industria. Última actualización: .

Datos proporcionados solo con fines informativos.

Notas de análisis
  • The cannabis industry is subject to rapid changes in regulations and market conditions.
  • The performance of BUDX is dependent on the performance of the cannabis sector.
  • The fund's non-diversified structure increases concentration risk.
Fuentes de datos

Popular Stocks